Akums Drugs and Pharmaceuticals Limited
Open MainLineCurrent GMP
₹43 (+6.33%)
Price Band
₹ 646 – 679
Lot Size
22
Issue Size
₹1856.74 Cr
Minimum Investment
₹14938 (22 Shares)
Listing Date
06 August 2024
Subscription
63.56x
About the Company
Akums Drugs and Pharmaceuticals Limited, established in 2004, is a leading pharmaceutical contract development and manufacturing organization (CDMO) providing a comprehensive range of products and services in India and internationally.
The company offers end-to-end solutions for product development, manufacturing, research and development (R&D) of formulations, regulatory dossier preparation, and submission, along with other testing services. Akums is also involved in the manufacture and sale of branded drugs and active pharmaceutical ingredients (APIs).
As a CDMO, Akums produces a variety of dosage forms, including tablets, capsules, liquid medicines, vials, ampoules, blow-filled closures, topical preparations, eye drops, dry powder injections, and gummy bears. The company has commercialised 4,025 formulations in over 60 dosage forms and, in 2023, manufactured formulations for 26 of India's top 30 pharmaceutical companies by revenue. Akums operates 10 manufacturing units with a cumulative production capacity of 49.21 billion units annually as of September 30, 2023.
Promoters
- Sanjeev Jain
- Sandeep Jain
- Akums Master Trust
Promoters Holding
Holding Pre Issue
84.94%
Holding Post Issue
0.00%
Objects of the Issue
The Company proposes to utilize the Net Proceeds towards the funding of the following objects:
- Repayment/ prepayment of indebtedness of the company and its Subsidiaries
- Funding incremental working capital requirements of the company
- Pursuing inorganic growth initiatives through acquisitions
- General corporate purposes.
Address / Contact Info
Akums Drugs and Pharmaceuticals Limited
304, Mohan Place,
LSC Saraswati Vihar,
Delhi - 110 034
Phone: +91 11 6904 1000
Email: cs@akums.net
Website: http://www.akums.in
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Tuesday, 30 July 2024
IPO Close Date
Thursday, 01 August 2024
Basis of Allotment
Friday, 02 August 2024
Initiation of Refunds
Monday, 05 August 2024
Credit of Shares to Demat
Monday, 05 August 2024
Listing Date
Tuesday, 06 August 2024 — NSE & BSE
Important Dates
Open Date
30 July 2024
Close Date
01 August 2024
Basis Of Allotment
02 August 2024
Listing Date
06 August 2024
Financial Performance (₹ in Crores)
| Particular | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Assets | 3516.37 | 3266.53 | 3069.05 |
| Revenue | 4212.21 | 3700.93 | 3694.52 |
| Profit After Tax | 0.79 | 97.82 | -250.87 |
| Net Worth | 709.5 | 717.19 | 621.98 |
| Reserve & Surplus | 861.01 | 868.7 | 787.79 |
| Total Borrowings | 491.56 | 536.97 | 357.95 |
EPS Pre
0.00%
EPS Post
0.00%
P/E Pre
0.00
P/E (Post Issue)
0.00x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | KPI as of March 31, 2024. |
|---|---|
| ROE % | 0.11 |
| ROCE % | 3.37 |
| Debt / Equity | 0.69 |
| RoNW % | -0.57 |
| PbW | 13.69 |
| Pat Margin % | 0.02 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Anchor Investors | 12205912 | 44.6 | 0 |
| Qualified Institutions | 8137276 | 29.73 | 0 |
| Non-Institutional | 4068637 | 14.87 | 0 |
| BNII | 2712425 | 9.91 | 8806 |
| SNII | 1356212 | 4.96 | 4403 |
| Retail Investors | 2712424 | 9.91 | 123292 |
| Employees | 243902 | 0.89 | 0 |
| Total | 27368151 | 100 | 0 |
Subscription Status ( Sat, 24 Aug 24 07:34 AM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 8137276 | 733117770 | 90.09x |
| Non-Institutional | 4068637 | 171750128 | 42.21x |
| BNII | 2712425 | 128649664 | 47.43x |
| SNII | 1356212 | 43100464 | 31.78x |
| Retail Investors | 2712424 | 57770020 | 21.3x |
| Employees | 243902 | 1041216 | 4.27x |
| Total | 15162239 | 963679134 | 63.56x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
No Peer Comparision Available
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 22 | 14,938.00 |
| Retail (Max) | 13 | 286 | 194,194.00 |
| S-HNI (Min) | 14 | 308 | 209,132.00 |
| S-HNI (Max) | 66 | 1,452 | 985,908.00 |
| B-HNI (Min) | 67 | 1,474 | 1,000,846.00 |
Registrar
MUFG Intime India Private Limited ((Link Intime)
91-22-4918 6270
ipo.helpdesk@in.mpms.mufg.com
https://in.mpms.mufg.com/home.html
Book Running Lead Managers
- Axis Bank Limited
- Citigroup Global Markets India Private Limited
- ICICI Securities Limited
- Ambit Private Limited
RHP Document
DRHP Document
Anchor Investors
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Akums Drugs and Pharmaceuticals Limited is a Book-building IPO worth ₹1856.74 crores. The price band is ₹646 to 679 per share. The IPO opens on Tue, Jul 30, 2024 and closes on Thu, Aug 1, 2024. It will be listed on BSE and NSE. MUFG Intime India Private Limited ((Link Intime) is the registrar.
The Akums Drugs and Pharmaceuticals Limited opens on Tue, Jul 30, 2024 and closes on Thu, Aug 1, 2024
Akums Drugs and Pharmaceuticals Limited Price Band is ₹646 to 679.
Akums Drugs and Pharmaceuticals Limited lot size is 22, and the minimum amount required for application is ₹14938.
The minimum investment for Akums Drugs and Pharmaceuticals Limited is approximately ₹14938 based on the upper price band.
To apply for the Akums Drugs and Pharmaceuticals Limited, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Thu, Aug 1, 2024. After submission, funds are blocked until the basis of allotment of Akums Drugs and Pharmaceuticals Limited is finalised.
Akums Drugs and Pharmaceuticals Limited issue size is ₹1856.74 crores.
Akums Drugs and Pharmaceuticals Limited allotment date is Sat, Jun 27, 2026.
The registrar for Akums Drugs and Pharmaceuticals Limited is MUFG Intime India Private Limited ((Link Intime). Investors can go to MUFG Intime India Private Limited ((Link Intime) website for IPO allotment status, refund processing, and other queries related to Akums Drugs and Pharmaceuticals Limited through their official website or helpline.
The Akums Drugs and Pharmaceuticals Limited GMP (Grey Market Premium) is ₹43 as of Tue, Aug 6, 2024. Based on the upper price band of ₹679 per share, the estimated Akums Drugs and Pharmaceuticals Limited listing price is ₹722, indicating a potential listing gain of approximately 31% over the issue price.